Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Doctors Identify Overused Tests And Procedures In ‘Choosing Wisely’ Campaign

This article was originally published in The Gray Sheet

Executive Summary

Physician specialty societies participating in the campaign each identified five tests or treatments that are commonly used but not always necessary.

You may also be interested in...



Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy

The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.

Research Briefs: Studies From Exact Sciences, EndoChoice; Neuroimaging Overuse

In the lead up to an FDA panel, positive data is published for Exact Science’s Cologuard multi-target stool DNA-based screening test. EndoChoice’s Fuse endoscope sees more colon cancer than traditional endoscopes. Overuse of neuroimaging for headaches documented. Long-term study finds high-frequency oscillatory ventilation is better for premature babies than standard ventilation. Drug-coated balloon trial.

Berwick Joins Growing Chorus Decrying Waste In Health Care

Editorial in the Journal of the American Medical Association says opportunity for waste reduction is enormous.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel